Theravance Biopharma (TBPH) Asset Utilization Ratio (2014 - 2026)

Theravance Biopharma (TBPH) has 13 years of Asset Utilization Ratio data on file, last reported at 0.23 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 22.52% year-over-year to 0.23 in Q1 2026; TTM through Mar 2026 was 0.23, a 22.52% increase from a year earlier, with the FY2025 full-year figure at 0.02, down 89.79% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.23, down from 0.24 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for TBPH reached as high as 0.24 in Q4 2025 and fell as low as 0.07 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.16 across 5 years, with a median of 0.16 in 2024.
• Across the five-year window, Asset Utilization Ratio plunged 47.32% in 2022 and soared 92.71% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.07 in 2022, then surged by 92.71% to 0.14 in 2023, then grew by 25.58% to 0.18 in 2024, then surged by 31.58% to 0.24 in 2025, then fell by 3.91% to 0.23 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.23 in Q1 2026, 0.24 in Q4 2025, and 0.19 in Q3 2025.